Paul J. Clancy, Executive VP and CFO at BIOGEN IDEC INC. (BIIB), sold 99,030 shares at $238.29 ($23.6M) on 2013-09-16, disclosed to the SEC on 2013-09-18.
Scheduled sale ($23.6M) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $236.94 | 9,000 | $2.1M | 9.0% |
| 2 | $236.99 | 4,227 | $1.0M | 4.2% |
| 3 | $237.05 | 2,500 | $593K | 2.5% |
| 4 | $237.05 | 4,400 | $1.0M | 4.4% |
| 5 | $237.05 | 1,600 | $379K | 1.6% |
| 6 | $237.93 | 14,708 |
| $3.5M |
| 14.8% |
| 7 | $238.00 | 7,503 | $1.8M | 7.6% |
| 8 | $238.12 | 5,165 | $1.2M | 5.2% |
| 9 | $238.12 | 7,221 | $1.7M | 7.3% |
| 10 | $238.29 | 2,825 | $673K | 2.9% |
| 11 | $238.56 | 11,134 | $2.7M | 11.3% |
| 12 | $238.65 | 4,300 | $1.0M | 4.3% |
| 13 | $238.80 | 3,269 | $781K | 3.3% |
| 14 | $239.00 | 1,525 | $364K | 1.5% |
| 15 | $239.54 | 1,475 | $353K | 1.5% |
| 16 | $239.75 | 9,098 | $2.2M | 9.2% |
| 17 | $239.76 | 3,970 | $952K | 4.0% |
| 18 | $239.79 | 3,210 | $770K | 3.3% |
| 19 | $239.84 | 1,800 | $432K | 1.8% |
| 20 | $240.20 | 100 | $24K | 0.1% |
| Total | $238.27 avg | 99,030 | $23.6M | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $1.4M | — | Filing → |
| BIIB | SELL | 2017-04-27 | $2.9M | — | Filing → |
| BIIB | SELL | 2017-03-14 | $5.8M | — | Filing → |